Companies: 10,795·Total market cap: $144.5T
Amarantus BioScience Holdings, Inc.

Amarantus BioScience Holdings, Inc.

AMBSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$36841
P/E Ratio
52W High$0.0003
52W Low$0.00001

Amarantus BioScience Holdings, Inc. (AMBS) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

AMBS · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
579.6M +24.62% YoY Change
FY · as of Dec 31, 2022 · Reported in USD
vs 465.1M in FY 2021
Diluted Shares Outstanding
579.6M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+24.62%
year-over-year
Float (Free Float)
368.4M
publicly tradable shares
100.0% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+29.0%
2019 → 2022
5-Year CAGRincreasing
+53.4%
2017 → 2022
10-Year CAGRincreasing
+90.2%
2012 → 2022

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2022Latest
Diluted Shares: 579.6M
579.6M
+24.62%
FY 2021
Diluted Shares: 465.1M
465.1M
+26.25%
FY 2020
Diluted Shares: 368.4M
368.4M
+36.49%
FY 2019
Diluted Shares: 269.9M
269.9M
+15.27%
FY 2018
Diluted Shares: 234.2M
234.2M
+242.98%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs AMBS
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+331.7%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+319.0%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+207.2%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+167.4%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+57.0%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+54.9%
#7
Amarantus BioScience Holdings, Inc.AMBS
Amarantus BioScience Holdings, Inc.YOU
579.6M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Amarantus BioScience Holdings, Inc. (AMBS) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2022, Amarantus BioScience Holdings, Inc. reports 579.6M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Amarantus BioScience Holdings, Inc.'s basic shares outstanding (579.6M) represents currently issued shares. Diluted shares outstanding (579.6M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Amarantus BioScience Holdings, Inc.'s float is 368.4M (100.0% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float368.4M(100.0%)
Outstanding368.4M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Amarantus BioScience Holdings, Inc. (AMBS) shares outstanding history from 2007 to 2022. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Amarantus BioScience Holdings, Inc. shares outstanding for the fiscal year ending December 31, 2022 were 579.6M, a 24.62% increase year-over-year. Amarantus BioScience Holdings, Inc. FY 2022 shares outstanding were 579.6M, a +24.62% increase from FY 2021.

Amarantus BioScience Holdings, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +90.2% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

AMBS shares outstanding · 4 questions

As of December 31, 2022, Amarantus BioScience Holdings, Inc. (AMBS) has approximately 579.6M basic shares outstanding and 579.6M diluted shares outstanding. This represents a +24.62% year-over-year increase from FY 2021 (465.1M). The increase may reflect equity compensation issuances or secondary offerings.

AMBS shares outstandinghow many shares does AMBS haveAMBS basic shares 2022AMBS diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Amarantus BioScience Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09